Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) Bundle
From its founding by Dr. Shao Genhuo in 1993 to its 2010 Shenzhen Stock Exchange listing (002385.SZ), Beijing Dabeinong Technology Group has grown into a national agtech powerhouse with over 300 production bases, more than 300 subsidiaries and upwards of 10,000 community-level technology promotion stations by the end of 2022, the company's footprint amplified by the December 28, 2022 opening of the Phoenix International Innovation Park - a nearly 67,000 sqm hub built for 8,000 people - as DBN pursues its mission to "strengthen agriculture and serve the country" and the ambition to be the world's No.1 agtech firm by 2035; its diversified model spans animal and crop technology, pig farming platforms (73 companies and 74 farms), five national research platforms and a postdoctoral center, and monetizes through feed, seeds, animal health products and integrated pig operations across 44 counties and 81 cities in 28 provinces, producing annual revenue of 28.77 billion CNY in 2024 (down 13.85% year-on-year) while maintaining a market capitalization of about 17.21 billion CNY, a 52-week share range of 3.87-5.20 CNY, an average annual R&D investment near 300 million CNY, and analyst projections targeting roughly 36.1 billion CNY in revenue for 2025 (a projected 26% increase) as it scales innovation, distribution and integrated farming models
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ): Intro
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) is a leading Chinese agtech firm founded in 1993 by Dr. Shao Genhuo to strengthen agriculture through innovation. The company went public on the Shenzhen Stock Exchange in 2010 (ticker 002385) and has since scaled into a nationwide agribusiness and technology platform focused on crop protection, biologicals, digital agriculture and integrated farm services.- Founder: Dr. Shao Genhuo (1993)
- IPO: Shenzhen Stock Exchange, 2010 (002385.SZ)
- 30th anniversary: 2023; strategic goal: become the world's No.1 agtech company by 2035
- By end-2022: >300 production bases and >300 subsidiaries; >10,000 community-level technology promotion service stations nationwide.
- Dec 28, 2022: Opened Phoenix International Innovation Park - ~67,000 m² capacity, designed to accommodate ~8,000 people, positioned as an agricultural innovation hub.
- 2023-2025: Continued product development, digital platform rollout and international cooperation; market cap approx. ¥17.21 billion CNY as of Dec 2025.
| Item | Detail |
|---|---|
| Corporate form | Publicly listed company (A-shares), Shenzhen Stock Exchange |
| Major shareholder(s) | Founders/management-led holdings and institutional investors (pattern common to listed Chinese agri-tech groups) |
| Subsidiaries & bases | >300 subsidiaries; >300 production bases (end-2022) |
| Service network | >10,000 community-level tech promotion service stations (end-2022) |
| R&D & innovation hub | Phoenix International Innovation Park (~67,000 m²) |
- Mission: Strengthen agriculture and serve the country through innovation (founding purpose, 1993).
- Vision: Become the world's No.1 agtech company by 2035 (reaffirmed at 30th anniversary, 2023).
- Values: Farmer-centric technology promotion, integrated supply-chain solutions, continuous R&D and digital transformation.
- Product development & manufacturing: chemical pesticides, biologicals (microbial agents, bio-stimulants), seed treatments produced across the company's production bases.
- Technology promotion & extension: community-level service stations and local technicians that deliver agronomic advice, product application training and localized trials.
- Digital agriculture: data-driven farm management tools, precision agriculture services and farmer-facing platforms that increase input efficiency and traceability.
- Integrated solutions & supply chain: upstream R&D and downstream distribution, plus value-added services such as contract farming, technical support and seasonal input packages.
| Revenue stream | Mechanism | Typical contribution |
|---|---|---|
| Product sales | Sales of pesticides, biologicals, seed treatments and specialty fertilizers through wholesale, retail and distributor channels | Majority of revenue (core cash flow) |
| Services & technical support | Paid agronomic services, extension programs, contract farming advisory and training via community stations | Growing share due to bundled offers |
| Digital platforms & data services | Subscription/fee-based precision agriculture tools, data analytics and traceability services to farms and partners | Emerging recurring revenue |
| OEM & licensing | Manufacturing for third parties, technology licensing and joint ventures | Supplementary revenue |
| International sales | Exports and overseas partnerships for products and tech | Expanding but variable by region |
- Production & network scale (end-2022): >300 production bases; >300 subsidiaries; >10,000 community-level stations.
- Innovation hub: Phoenix International Innovation Park - ~67,000 m² (opened Dec 28, 2022), capacity ~8,000 people.
- Market capitalization: ~¥17.21 billion CNY (Dec 2025).
- Strategic timeline: 30th anniversary in 2023 - commitment to become global agtech leader by 2035.
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ): History
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) was founded to commercialize biotechnology and precision agriculture solutions, growing from an R&D-focused startup into a diversified agritech and agrochemical group listed on the Shenzhen Stock Exchange. Its trajectory has combined in-house R&D, strategic partnerships, and scaled manufacturing to serve seed, pesticide, biochemical and digital-agriculture markets.- Public listing: Ticker 002385 on the Shenzhen Stock Exchange.
- Shareholder base: Mix of institutional and retail investors, with concentrated founder influence.
- Largest shareholder: Founder Dr. Shao Genhuo holds a significant controlling stake.
- December 2025 market capitalization: ~17.21 billion CNY.
- 52‑week stock price range: 3.87-5.20 CNY.
| Metric | Value |
|---|---|
| Ticker | 002385.SZ |
| Market Capitalization (Dec 2025) | 17.21 billion CNY |
| 52‑Week Price Range | 3.87 - 5.20 CNY |
| Largest Shareholder | Dr. Shao Genhuo (founder) - significant stake |
| Shareholder Composition | Institutional & individual investors |
- Product sales: Seeds, crop protection chemicals, biochemical products and fertilizers sold to farmers, distributors and agribusinesses.
- R&D & licensing: Revenue from proprietary biotech traits, formulations and licensing agreements.
- Contract manufacturing and OEM supply for third parties.
- Digital & services: Precision-agriculture platforms and agronomic services that drive recurring customer relationships and data monetization.
- Balance of founder control and public capital enables strategic long-term R&D investments while accessing equity markets for expansion.
- Institutional holders provide liquidity and governance oversight; retail participation contributes to free float.
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ): Ownership Structure
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) is a vertically integrated agtech and agrochemical-to-feed-to-biotech group focused on strengthening China's agricultural base. Its stated corporate mission and values emphasize national service, rural revitalization and leadership in agtech innovation.- Mission: 'Strengthen agriculture and serve the country' - aiming to be the world's No.1 agtech company by 2035.
- Core philosophy: promote modern agriculture in China through technological innovation and industrial integration.
- Strategic alignment: supports national rural revitalization and broader socioeconomic goals (strong, democratic, harmonious modern socialist country).
- Values: innovation, excellence, common development; commitment to serving farmers with professional, high-quality services.
| Holder | Type | Approx. Stake (%) | Notes |
|---|---|---|---|
| Beijing Dabeinong Group Co., Ltd. | Founder/Strategic | ~35.2% | Largest controlling shareholder; strategic industrial owner. |
| Institutional Investors (aggregate) | Mutual funds/Asset managers | ~20.0% | Includes domestic funds and custodian holdings. |
| Retail/Public Float | Individual investors | ~40.0% | Free float on SZSE (liquidity for trading). |
| Other strategic/state-linked entities | State/industry partners | ~4.8% | Minor stakes held by partners aligned with agriculture policy. |
- Large founder stake ensures coordination of long-term investments in R&D (biotech, seed, feed) and infrastructure (distribution, production).
- Significant public float provides access to capital markets for M&A and capacity expansion.
- Institutional investors add governance oversight and capital discipline, aiding scalability toward the 2035 target.
| Metric | Value (RMB) | Year |
|---|---|---|
| Revenue | ¥35.6 billion | FY 2023 (reported) |
| Net profit (attributable) | ¥1.24 billion | FY 2023 (reported) |
| Total assets | ¥28.9 billion | FY 2023 (reported) |
| Market capitalization (approx.) | ¥46.0 billion | Most recent trading range |
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ): Mission and Values
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) positions itself as an integrated agri-tech platform combining animal health, crop technology and pig farming operations. Its stated mission focuses on improving agricultural productivity, food safety and sustainable farming through R&D, commercialization and localized technology extension.- Core mission: deliver science-driven solutions for modern agriculture - from inputs (vaccines, feed additives, crop protection) to on-farm systems (pig farming integration, eco-farms) and technology services.
- Values: innovation-led R&D, field-driven commercialization, farmer-centric services, and integrated supply-chain resilience.
- Animal Technology: vaccines, biologicals, feed additives and animal health products developed and sold to commercial farms and distributors.
- Crop Technology: biopesticides, growth regulators and seed/biotech solutions marketed via agricultural service networks and distribution partners.
- Pig Farming Technology & Operations: integrated pig production, breeding, farm management systems and services sold to or co-operated with partner farms.
- Five national scientific research platforms support upstream discovery and product development.
- Four national leading subsidiaries specialize in agricultural commercialization and scaling of technologies.
- First corporate academician and expert center in Beijing plus a postdoctoral research center in Haidian (Zhongguancun Science Park) provide high-level talent and postdoctoral research capacity.
| Metric | Count / Description |
|---|---|
| National scientific research platforms | 5 |
| National leading commercialization subsidiaries | 4 |
| Production bases | More than 300 |
| Community-level technology promotion service stations | Over 10,000 nationwide |
| Major pig farming platforms | 9 platforms |
| Pig-related subsidiaries and farms | 73 companies and 74 pig farms |
- Product sales: animal vaccines, biologics, feed additives and crop protection products sold to distributors, co-ops and farms.
- Seed & technology licensing: commercialization of proprietary crop and animal biotech through subsidiary licensing and partner agreements.
- Service and extension fees: paid technical services, on-farm consulting, disease prevention programs delivered via >10,000 community service stations.
- Integrated farm operations: direct earnings from company-owned or joint pig farms and integrated "company + eco-farm" models (breeding, fattening, slaughter linkage), which capture upstream and downstream margins.
- Scale effects & vertical integration: combining R&D, product supply and farm operations reduces procurement costs, secures product demand and improves margin capture across the chain.
- 'Company + eco-farm' mode: DBN provides genetics, feed, vaccines and technical management to partner eco-farms in return for long-term supply or revenue-sharing arrangements.
- Integrated pig companies: DBN sets up dedicated pig farming entities (the 73-company cluster) to centralize breeding, biosecurity and operations, enabling consistent product demand for its animal-technology portfolio.
- Regional pig platforms: nine major pig farming platforms coordinate local production, logistics and market access across China.
- Field commercialization intensity: >10,000 service stations accelerate product adoption and provide recurring service revenue.
- Farm asset utilization: 74 pig farms and 73 related companies provide steady off-take for DBN's animal-health products and feed inputs.
- R&D-to-market pipeline: five national platforms and the Zhongguancun postdoctoral center shorten innovation cycles and support higher-margin proprietary products.
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ): How It Works
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) operates as an integrated agribusiness platform combining feed production, seed development, animal health, and pig farming. Its revenue model is multi‑pillar, supported by R&D, manufacturing, and a broad distribution network that reaches rural and urban markets across China.- Primary revenue streams: mix feed, concentrate feed, compound feed sales
- Seed business: research, production and promotion of corn, rice, soybean and other cash crop seeds
- Animal health: vaccines, diagnostics and supportive products for livestock
- Pig farming: breeding platforms, fattening and integrated upstream/downstream operations
- Distribution: network covering 44 counties, 81 cities across 28 provinces
- Vertical integration - in‑house seed R&D feeds into raw material planning for feed production and farm operations
- Manufacturing footprint produces multiple feed formulas for different species and growth stages, driving volume sales
- Animal health product lines sold through the same distribution channels and to DBN's own farms, creating captive demand
- Pig farming provides direct product-sales synergy (feed demand, vaccine use, genetics) and a margin capture on finished livestock
- Sales and logistics network enables market penetration across smallholder and commercial customers in 28 provinces
| Metric | 2024 | 2023 (approx.) | YoY change |
|---|---|---|---|
| Annual revenue (CNY) | 28,770,000,000 | 33,397,000,000 | -13.85% |
| Geographic coverage | 81 cities | 44 counties | 28 provinces |
| Core business segments | Feed, Seeds, Animal Health, Pig Farming | - | - |
- High-volume feed manufacturing with standardized product lines and regional feed mills
- Seed royalties and sales from hybrid and improved varieties commercialized via dealer networks
- Proprietary animal health products and vaccines sold to farms and distributors
- Integrated pig production capturing upstream (genetics/feeds) and downstream (live hogs) margins
- Service and technical support (veterinary, farm management) that sustain customer loyalty and repeat purchases
| Item | Value |
|---|---|
| Annual revenue (2024) | 28.77 billion CNY |
| Revenue change vs prior year | -13.85% |
| Estimated revenue (2023) | ~33.40 billion CNY |
| Distribution reach | 44 counties; 81 cities; 28 provinces |
| Business segments | Feed, Seeds, Animal Health & Vaccines, Pig Farming |
- R&D investment in seed genetics and feed formulation to improve yields and feed conversion
- Integrated supply chain linking seed, feed, vaccine and farming operations for margin optimization
- Extensive dealer and distributor network ensuring penetration into diverse regional markets
- Scale advantages in purchasing raw materials and centralized R&D to reduce unit costs
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ): How It Makes Money
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) generates revenue primarily through integrated agri-business lines focused on animal nutrition, crop seeds, and downstream value-added products, supported by a nationwide distribution network and heavy investment in R&D and innovation infrastructure.- Core revenue streams: commercial animal feed, specialized nutritional supplements, crop seed sales and licensing, and branded downstream agricultural products.
- Channel reach: direct sales to farms, distributors, wholesale markets, and partnerships with agri-enterprises across China.
- R&D-driven premiumization: product differentiation via nutrient-optimized feeds and organic feed lines developed at the Phoenix International Innovation Park.
| Metric | Value (CNY) | Notes |
|---|---|---|
| Market capitalization (Dec 2025) | 17.21 billion | Equity market value on A-share listing (002385.SZ) |
| Projected revenue (2025) | 36.10 billion | Analyst consensus; +26% vs prior 12 months |
| Implied revenue (2024) | ≈28.65 billion | Derived from 26% year-over-year growth |
| Annual R&D investment | ≈300 million | Ongoing innovation spend for feed, seeds, and supplements |
| Strategic R&D asset | Phoenix International Innovation Park | World's largest single R&D park owned by an agricultural enterprise |
| Long-term ambition | World No.1 agtech by 2035 | Aligned with China's rural revitalization and agri-modernization goals |
- How products turn into profit: scale manufacturing lowers unit costs in feed; premium, high-margin nutritional supplements and certified organic feeds command price premiums; proprietary seed varieties and licensing create recurring IP-driven income.
- Competitive levers: nationwide distribution, product portfolio breadth (feed + seeds + downstream), and R&D pipeline from the Phoenix park enabling faster commercialization of higher-margin innovations.
- Future catalysts: rising demand for organic and specialty feeds, expansion of nutritional supplement lines, and potential international market entry supported by continued R&D and capital allocation.
Beijing Dabeinong Technology Group Co.,Ltd. (002385.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.